Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-30

Clinical Trial Update: Study of the Efficacy and Safety of Remimazolam in General Anesthesia in Adults Undergoing Cardiac Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of remimazolam for general anesthesia in adults undergoing cardiac surgery has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remimazolam (remimazolam)

Snippet

Sponsor: Paion UK Ltd. | Conditions: Anesthesia | Phase 3 | Status: TERMINATED